Author

Xiaoyi Qu

Columbia University Irving Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Assay:proteomics· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

Atul KumariD· 2 shared Francesca BartoliniiD· 2 shared Maria Elena PeroiD· 2 shared Alain BuissoniD· 1 shared Andrew A. SprouliD· 1 shared Annie AndrieuxiD· 1 shared Benjamin Di Cara· 1 shared C MeregalliiD· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Atul KumarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Impaired α-tubulin re-tyrosination leads to synaptic dysfunction and is a feature of Alzheimer's disease

Leticia Peris, Xiaoyi Qu, Jean-Marc Soleilhac, Julie Parato, Fabien Lanté, Atul Kumar, Maria Elena Pero, José Martínez Hernández, Charlotte Corrao, Giulia Falivelli, Floriane Payet, Sylvie Gory‐Fauré, Christophe Bosc, Marian Blanca Ramírez, Andrew A. Sproul, , Annie Andrieux

bioRxiv · May 17, 2021 · PreprintNeuroscience

Pathogenic Role of Delta 2 Tubulin in Bortezomib Induced Peripheral Neuropathy

Maria Elena Pero, C Meregalli, Xiaoyi Qu, Grace Ji-eun Shin, Atul Kumar, Matthew Shorey, Melissa M. Rolls, Kurenai Tanji, Thomas H. Brannagan, Paola Alberti, G Fumagalli, Laura Monza, Wesley B. Grueber, Guido Cavaletti, Francesca Bartolini

This study identifies delta 2 tubulin as a key player in bortezomib-induced peripheral neuropathy by showing its role in axonopathy and mitochondrial motility disruption.

Proceedings of the National Academy of Sciences · Jan 19, 2021Peer-reviewedNeuroscience